Dementia Prevention in Women: A Menopause and Brain Health Perspective from Connecticut

Dr. Courtney Holmes, APRN, Founder of Milford Med Spa & Wellness

I am angry.

I am angry at the continuing education on dementia that I pursued in good faith, at the geriatric specialist certification that I earned, the conferences I attended, the journals I read, and the institutions I trusted.

Because after more than twenty years as a geriatric nurse practitioner, after dedicating my career to aging, cognitive decline, and dementia, NOT ONCE was I formally taught to consider estrogen as a variable in brain aging.

Not once.

Why Are Women More Likely to Develop Alzheimer’s Disease?

For two years, I practiced inside an academic medical institution devoted to aging and dementia research. I evaluated patients. I diagnosed cognitive impairment. I supported families navigating Alzheimer’s disease and related dementias.

We discussed:

Amyloid plaques
Tau tangles
Genetics
Imaging
Pharmacologic management

We did not discuss:

Menopause
Estrogen loss
The largest neuroendocrine transition in a woman’s life

That omission was not neutral. Nearly two-thirds of Americans living with Alzheimer’s disease are women (Alzheimer’s Association).

At age 45, a woman’s lifetime risk of Alzheimer’s is approximately 1 in 5, compared with about 1 in 10 for men. We should be asking why the disparity? Longevity explains some of it, but not all of it.

And yet women’s hormonal transitions remain under-integrated in dementia prevention conversations.

Menopause and Brain Health: A Neurologic Transition, Not Just a Reproductive One

We must shift our thinking. Menopause is not simply the end of fertility. It is a systemic, neuroendocrine transition.

Research has demonstrated that during the menopausal transition, declining estrogen is associated with measurable changes in:

Brain glucose metabolism
Mitochondrial function
Structural connectivity
Alzheimer’s disease biomarkers

Major reviews and imaging studies (Mosconi et al., Endocrine Reviews; Scientific Reports; PLOS ONE) show that these changes are distinct from normal chronological aging (gender specific).

This does not mean estrogen loss alone causes dementia. We realize there are other factors at play. But it does mean menopause is biologically relevant to brain aging. Ignoring that is no longer scientifically defensible.

The Research Gap in Women’s Brain Health

~2/3 of people living with Alzheimer’s are women
Women have roughly double the lifetime risk
Menopause is associated with measurable neurologic shifts
Women-only dementia prevention trials remain rare
Many studies fail to stratify outcomes by hormonal status
Research funding prioritizes late-stage treatment over midlife prevention

We are investing in rescue, not prevention. And women are paying the price.

Hormone Therapy and Dementia Risk: What the Evidence Actually Says

The Women’s Health Initiative Memory Study found that initiating certain oral hormone regimens in women over age 65 was associated with increased dementia risk. Hormone therapy is not recommended as a treatment for dementia. That is clear.

But that study does not answer:

What happens when estrogen declines in midlife
Whether timing of initiation matters
Whether transdermal vs oral routes differ
How hormones interact with sleep, vascular health, insulin resistance, and inflammation over decades

Complexity is not a reason for lack of research. Indeed, it should be a reason for more of it.

Only 5% of Eligible Women Use Menopausal Hormone Therapy

National analyses published in JAMA Health Forum estimate that only about 4.7–5% of U.S. women use menopausal hormone therapy.

This reflects:

Clinician fear
Outdated education
Misinterpretation of early WHI data
Underinvestment in women-centered research

Not every woman should use hormones. But every woman deserves an informed, individualized conversation.

My 20-Year Perspective from Geriatrics

For two decades, I have watched dementia dismantle lives:

Women losing independence and then identity
Spouses becoming caregivers
Adult children grieving someone still alive
Families hemorrhaging emotional and financial resources

This is not theoretical. It is lived suffering.

And once you have witnessed it repeatedly, you cannot accept inevitability without questioning prevention.

Change the Statistic: Menopause Care and Dementia Prevention in Connecticut

If we want different outcomes for women, we must intervene earlier.

We must:

Recognize menopause as neurologic
Address cognitive symptoms in midlife
Integrate hormone evaluation thoughtfully
Optimize sleep, vascular health, metabolic function, and inflammation
Advocate for research funding centered on women

Prevention does not begin at 75. It begins in midlife.

Know Your Hormones. Know Your Options.

You do not need to receive care from us. But you do deserve evidence-based menopause care somewhere.

The Menopause Society provides clinical guidance and patient education resources regarding menopausal hormone therapy and individualized risk assessment. You can explore their resources at: https://www.menopause.org

Look for clinicians who:

Practice individualized risk assessment
Understand timing and route nuances
Review cardiovascular and metabolic history
Engage in shared decision-making
Reassess over time

Insurance-Based Menopause Consultations in Connecticut

If you are located in Connecticut, Milford Med Spa & Wellness offers structured, insurance-based menopause evaluations for eligible patients.

These visits include:

Comprehensive history
Risk stratification
Lab evaluation
Review of family cardiovascular and cognitive risk
Discussion of hormone and non-hormone options
Prevention-focused care planning

Our goal is that women receive informed care.

This Is Bigger Than Hormones

This is about:

Research equity
Sex-specific medicine
Prevention strategy
Clinical courage

Women deserve more than late diagnoses and early losses. They deserve to be centered. They deserve rigor. They deserve investment.

Know your hormones.
Know your options.
Ask informed questions.

And refuse to accept dismissal where science exists.

I Was Trained to Treat Dementia. No One Ever Taught Me to Prevent It in Women.